Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts.
Williams, CM; Muhammad, AK; Sambou, B; Bojang, A; Jobe, A; Daffeh, GK; Owolabi, O; Pan, D; Pareek, M; Barer, MR; SUTHERLAND, JS; Haldar, P;
2022
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2022).76 3 10.1093/cid/ciac455.
Qualitative and quantitative data for tuberculosis Infection prevention and control in South Africa (KwaZulu-Natal and Western Cape).
GRANT, A; Kielmann, K;
2022
, London School of Hygiene & Tropical Medicine (London, United Kingdom, South Africa) (2022). 10.17037/DATA.00002919.
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
Jayawardana, S; WEERASURIYA, CK; Pelzer, PT; SEELEY, J; Harris, RC; Tameris, M; Tait, D; WHITE, RG; Asaria, M;
2022
npj Vaccines, (2022).7 1 10.1038/s41541-022-00554-1.
Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa.
Beckwith, PG; Karat, AS; GOVENDER, I; Deol, AK; MCCREESH, N; Kielmann, K; BAISLEY, K; GRANT, AD; Yates, TA;
2022
PLOS Global Public Health, (2022).2 11 10.1371/journal.pgph.0000603.
Considering equity in priority setting using transmission models: Recommendations and data needs.
Quaife, M; MEDLEY, GF; JIT, M; Drake, T; Asaria, M; Van Baal, P; Baltussen, R; Bollinger, L; BOZZANI, F; BRADY, O; Broekhuizen, H; Chalkidou, K; Chi, Y-L; Dowdy, DW; Griffin, S; Haghparast-Bidgoli, H; Hallett, T; Hauck, K; Hollingsworth, TD; MCQUAID, CF; Menzies, NA; Merritt, MW; Mirelman, A; Morton, A; RUIZ, FJ; ... Gomez, GB.
2022
Epidemics, (2022).41, 10.1016/j.epidem.2022.100648.
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design.
Benest, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 11 10.3390/vaccines10111838.
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low- and middle-income countries.
Portnoy, A; Clark, R; WEERASURIYA, C; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.10.29.22281678.
Know your tuberculosis epidemic-Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?.
RICKMAN, HM; Kamchedzera, W; SCHWALB, A; Phiri, MD; Ruhwald, M; Shanaube, K; Dodd, PJ; HOUBEN, RM G J; CORBETT, EL; MacPherson, P;
2022
PLoS global public health, (2022).2 10 10.1371/journal.pgph.0001208.
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Rhodes, S; Smith, N; Evans, T; WHITE, R;
2022
Vaccine, (2022).40 49 10.1016/j.vaccine.2022.10.012.
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.
CRyPTIC Consortium,;
2022
The European respiratory journal, (2022).60 4 10.1183/13993003.00239-2022.